Abstract
BACKGROUND: Non-suicidal self-injury (NSSI) is associated with mental disorders, yet work regarding the direction of this association is inconsistent. We examined the prevalence, comorbidity, time-order associations with mental disorders, and sex differences in sporadic and repetitive NSSI among emerging adults. METHODS: We used survey data from n = 72,288 first-year college students as part of the World Mental Health-International College Student Survey Initiative (WMH-ICS) to explore time-order associations between onset of NSSI and mental disorders, based on retrospective age-of-onset reports using discrete-time survival models. We distinguished between sporadic (1-5 lifetime episodes) and repetitive (≥6 lifetime episodes) NSSI in relation to DSM-5 mood, anxiety, and externalizing disorders. RESULTS: We estimated a lifetime NSSI rate of 24.5%, with approximately half reporting sporadic NSSI and half repetitive NSSI. The time-order associations between onset of NSSI and mental disorders were bidirectional, but mental disorders were stronger predictors of the onset of NSSI (median RR = 1.94) than vice versa (median RR = 1.58). These associations were stronger among individuals engaging in repetitive rather than sporadic NSSI. While associations between NSSI and mental disorders generally did not differ by sex, repetitive NSSI was a stronger predictor for the onset of subsequent substance use disorders among females compared to males. Most mental disorders marginally increased the risk for persistent repetitive NSSI (median RR = 1.23). CONCLUSIONS: Our findings offer unique insights into the temporal order between NSSI and mental disorders. Further work exploring the mechanism underlying these associations will pave the way for early identification and intervention of both NSSI and mental disorders.
| Original language | English |
|---|---|
| Article number | e280 |
| Pages (from-to) | 1-15 |
| Number of pages | 15 |
| Journal | Psychological Medicine |
| Volume | 55 |
| Early online date | 25 Sept 2025 |
| DOIs | |
| Publication status | Published - 2025 |
Bibliographical note
Publisher Copyright:© The Author(s), 2025. Published by Cambridge University Press.
Funding
RB reports grant funding from Eli Lilly (IIT-H6U-BX-I002). DDE has served as a consultant to/on the scientific advisory boards of Sanofi, Novartis, Minddistrict, Lantern, Schoen Kliniken, Ideamed, and German health insurance companies (BARMER, Techniker Krankenkasse) and a number of federal chambers for psychotherapy. He is also shareholder of ‘GET.ON Institut für Online Gesundheitstrainings GmbH für Gesundheitstrainings online GmbH’ (HelloBetter), which aims to implement scientific findings related to digital health interventions into routine care. XH has received grants from Sexual Violence Research Institute, Volkswagen Foundation, Wellspring Philanthropies, Foreign, Commonwealth and Development Office (UK government), PANDA Holding Limited, National Research Foundation of South Africa, Center for Inclusive Policy. XH reports consulting fees from Mastercard Foundation, Missing Billion Initiative, UNICEF, International Food Policy Research Institute and the African Union. Hunt has received funding support to attend conferences from Mastercard Foundation and Charité University (Germany). MMH reports consulting fees from Child Mind Institute, New York. South Africa: The work reported herein was made possible through funding by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the MCSP (awarded to JB and XH). The World Mental Health International College Student (WMH-ICS) initiative is carried out as part of the World Mental Health (WMH) Survey Initiative. The WMH survey is supported by the National Institute of Mental Health NIMH R01MH070884, the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb (RCK). In the past 3 years, Dr. Kessler was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Child Mind Institute, Holmusk, Massachusetts General Hospital, Partners Healthcare, Inc., RallyPoint Networks, Inc., Sage Therapeutics and University of North Carolina. He has stock options in Cerebral Inc., Mirah, PYM (Prepare Your Mind), Roga Sciences and Verisense Health. GK had received funding from the Research Foundation Flanders (12ZZM21N/1204924 N). MKN receives publication royalties from Macmillan, Pearson, and UpToDate. He has been a paid consultant in the past 3 years for Cambridge Health Alliance, and for legal cases regarding a death by suicide. He has stock options in Cerebral Inc. He is an unpaid scientific advisor for Empatica, Koko, and TalkLife. DJS reports personal fees from Discovery Vitality, Johnson & Johnson, Kanna, L’Oreal, Lundbeck, Orion, Sanofi, Servier, Takeda, and Vistagen. DVV reports grant support from Health Canada, Canadian Institutes for Health Research, Provincial Health Services Authority and an internal research grant from the University of British Columbia. He received payments from the Canadian Ministry of Health and the Department of Interior Health for projects related to mental health service provision. Australia: PH has received funding for this work from Suicide Prevention Australia, the Feilman Foundation, and the National Health and Medical Research Council (ID 2032058). Saudi Arabia: The Saudi University Mental Health Survey is conducted by the King Salman Center for Disability Research; funded by Saudi Basic Industries Corporation, King Abdulaziz City for Science and Technology, Ministry of Health (Saudi Arabia) and King Saud University. Funding in-kind was provided by King Faisal Specialist Hospital & Research Center, and Ministry of Economy & Planning, General Authority for Statistics, Riyadh. The Netherlands: ZonMw (Netherlands Organisation for Health Research and Development; grant number 636110005) and the PFGV (PFGV; Protestants Fonds voor de Geestelijke Volksgezondheid) in support of the student survey project. Spain: The PROMES-U study, is supported by Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union, grant number PI20/00006; the Departament de Recerca i Universitats of the Generalitat de Catalunya (AGAUR 2021 SGR 00624); and CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB06/02/0046), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea. For surveys directed by Parc Sanitari Sant Joan de Déu, funding was provided by Fundació Sant Joan de Déu. Northern Ireland: The Student Psychological Intervention Trial (SPIT) was supported by Clinical Healthcare Intervention Trials in Ireland Network (CHITIN). CHITIN has received €10.6 million funding from the European Union’s INTERREG VA programme managed by the Special EU Programmes Body (SEUPB) with match funding from the Departments of Health in NI and ROI (CHI/5433/18). Romania:This work was supported by Romanian National Authority for Scientific Research, CNCS—UEFISCDI, Grant number PN-III-P2–2.1-PED-2021-3882, awarded to OD. Chile: VM, JG, ÁIL, and DN received funding from ANID/Millennium Science Initiative Program-NCS2021_081 and ANID/FONDECYT 1221230. New Zealand: The WMH-ICS NZ surveys were supported by a Rutherford Discovery Fellowship awarded to Associate Professor Damian Scarf, with additional support from the James Hume Bequest Fund and a research grant from University of Otago. SM-G received funding from ANID/Millennium Science Initiative Program-NCS2021_081 and ANID/PFCHA/DOCTORADO EN EL EXTRANJERO BECAS CHILE/2019–72200092. Belgium: The Belgian Fund for Scientific Research (11N0514N/11N0516N/ 1114717 N), the King Baudouin Foundation (2014-J2140150–102905) (RB), the Ministry of Education, Flanders - Grant# EDC-E3738, institutional payment, awarded to RB. Sweden: CA, MB and AHB received funding for this work from the Swedish Research Council (ID 2019–01127) as well as from a Public Health Agency in Sweden (ID 04252–2021-2.3.2). Both grants were awarded to AHB.
| Funders | Funder number |
|---|---|
| Volkswagen Foundation | |
| South African Medical Research Council | |
| Charité University | |
| Eli Lilly and Company | |
| Canadian Institutes for Health Research | |
| Sexual Violence Research Institute | |
| Health Canada | |
| Provincial Health Services Authority | |
| Feilman Foundation | |
| Saudi Basic Industries Corporation | |
| Protestants Fonds voor de Geestelijke Volksgezondheid | |
| Departament de Recerca i Universitats | |
| Mastercard Foundation | |
| Ministerio de Ciencia e Innovación and Unión Europea | |
| King Abdulaziz City for Science and Technology, Ministry of Health | |
| King Saud University | |
| EU Programmes Body | |
| ZonMw | |
| Generalitat de Catalunya | |
| Instituto de Salud Carlos III | |
| National Authority for Scientific Research | |
| Pan American Health Organization | |
| John D. and Catherine T. MacArthur Foundation | |
| ANID | |
| University of Otago | |
| PFCHA | |
| GlaxoSmithKline | |
| National Research Foundation of South Africa | |
| Suicide Prevention Australia | |
| Saudi University Mental Health Survey | |
| University of British Columbia | |
| James Hume Bequest Fund | |
| Pfizer Foundation | |
| PANDA Holding Limited | |
| CNCS | |
| CIBER | |
| Ortho-McNeil Pharmaceutical | |
| SEUPB | |
| National Institute of Mental Health NIMH | R01MH070884 |
| Fogarty International Center | FIRCA R03-TW006481 |
| Departments of Health in NI | CHI/5433/18 |
| US Public Health Service | R01 DA016558, R13-MH066849, R01-MH069864 |
| Belgian Fund for Scientific Research | 11N0514N/11N0516N/ 1114717 N |
| Research Foundation Flanders | 12ZZM21N/1204924 N |
| Ministry of Education, Flanders | EDC-E3738 |
| Netherlands Organisation for Health Research and Development | 636110005 |
| European Union | PI20/00006 |
| UEFISCDI | PN-III-P2–2.1-PED-2021-3882 |
| Fondecyt | 1221230 |
| Eli Lilly | IIT-H6U-BX-I002 |
| Swedish Research Council | 2019–01127 |
| Consorcio Centro de Investigación Biomédica en Red | CB06/02/0046 |
| AGAUR | 2021 SGR 00624 |
| Doctorado | CHILE/2019–72200092 |
| National Health and Medical Research Council | 2032058 |
| King Baudouin Foundation | 2014-J2140150–102905 |
| Public Health Agency in Sweden | 04252–2021-2.3.2 |
Keywords
- college students
- mental disorders
- non-suicidal self-injury
- NSSI